Cardiac teratogenicity in mouse maternal phenylketonuria: defining phenotype parameters and genetic background influences

scientific article

Cardiac teratogenicity in mouse maternal phenylketonuria: defining phenotype parameters and genetic background influences is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.YMGME.2012.08.001
P932PMC publication ID3504168
P698PubMed publication ID22951387

P50authorKim L. McBrideQ37371145
P2093author name stringNikki J Seagraves
P2860cites workCoordinating tissue interactions: Notch signaling in cardiac development and diseaseQ26822995
The incidence of congenital heart diseaseQ29614195
The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformationsQ30776464
The polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for QTL discovery and systems geneticsQ31120643
Genealogies of mouse inbred strainsQ33806120
jumonji gene is essential for the neurulation and cardiac development of mouse embryos with a C3H/He backgroundQ33870890
Mouse models of human phenylketonuriaQ33961407
Ethanol teratogenesis in five inbred strains of miceQ34181659
Heterogeneity of genetic modifiers ensures normal cardiac developmentQ34193363
Epidemiology of noncomplex left ventricular outflow tract obstruction malformations (aortic valve stenosis, coarctation of the aorta, hypoplastic left heart syndrome) in Texas, 1999-2001Q34338168
National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000.Q34388027
The cephalic neural crest exerts a critical effect on forebrain and midbrain developmentQ35080427
Developmental anatomy of the heart: a tale of mice and man.Q35581652
Effects of dietary management of phenylketonuria on long-term cognitive outcomeQ36154575
Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics.Q36829209
Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of PediaQ36829213
Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ miceQ37264435
NOTCH1 mutations in individuals with left ventricular outflow tract malformations reduce ligand-induced signalingQ37294787
An efficient SNP system for mouse genome scanning and elucidating strain relationships.Q37496419
Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses.Q37685646
The effects of high phenylalanine concentration on chick embryonic developmentQ37827351
Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnanciesQ40364201
Effect of maternal blood phenylalanine level on mouse maternal phenylketonuria offspringQ40671745
Early human development and the chief sources of information on staged human embryosQ41212347
The international study of pregnancy outcome in women with maternal phenylketonuria: report of a 12-year studyQ41722149
Nasomaxillary hypoplasia and severe orofacial clefting in a child of a mother with phenylketonuriaQ41922943
Congenital heart disease in maternal phenylketonuria: report from the Maternal PKU Collaborative StudyQ43592447
Emotional outcome of adolescents and young adults with early and continuously treated phenylketonuriaQ43793544
Developmental neurotoxicity: do similar phenotypes indicate a common mode of action? A comparison of fetal alcohol syndrome, toluene embryopathy and maternal phenylketonuriaQ44019760
How practical are recommendations for dietary control in phenylketonuria?Q44061671
Congenital cardiovascular malformations: questions on inheritance. Baltimore-Washington Infant Study GroupQ45884803
Metabolic phenotypes of phenylketonuria. Kinetic and molecular evaluation of the Blaskovics protein loading test.Q45927134
Effects of genetic background on cardiovascular anomalies in the Ts16 mouseQ46419766
Frontal lobe-dependent functions in treated phenylketonuria: blood phenylalanine concentrations and long-term deficits in adolescents and young adultsQ46497893
Abnormal expression of genes associated with development and inflammation in the heart of mouse maternal phenylketonuria offspringQ46705037
Blood phenylalanine monitoring for dietary compliance among patients with phenylketonuria: comparison of methodsQ46897326
Cardiac neural crest cells provide new insight into septation of the cardiac outflow tract: aortic sac to ventricular septal closure.Q52188159
Cardiovascular Defects among the Progeny of Mouse Phenylketonuria FemalesQ52193955
Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome ProjectQ57315750
Life span of specified-pathogen-free (MRC category 4) mice and ratsQ70729585
Characterization of mutations at the mouse phenylalanine hydroxylase locusQ73269192
Patterning the vertebrate heartQ74399546
Conotruncal myocardium arises from a secondary heart fieldQ77102388
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studiesQ80867983
Generation n + 1: Projected numbers of babies born to women with PKU compared to babies with PKU in the United States in 2009Q83865274
P433issue4
P921main subjectphenylketonuriaQ194041
teratogenicityQ56246640
maternal phenylketonuriaQ68430440
P304page(s)650-658
P577publication date2012-08-08
P1433published inMolecular Genetics and MetabolismQ6895949
P1476titleCardiac teratogenicity in mouse maternal phenylketonuria: defining phenotype parameters and genetic background influences
P478volume107

Reverse relations

cites work (P2860)
Q26744450Genetic Evaluation and Use of Chromosome Microarray in Patients with Isolated Heart Defects: Benefits and Challenges of a New Model in Cardiovascular Care
Q41929459Methylome repatterning in a mouse model of Maternal PKU Syndrome.
Q90842272RNA-Seq analysis in an avian model of maternal phenylketonuria
Q90428534Uric acid: a potent molecular contributor to pluripotent stem cell cardiac differentiation via mesoderm specification

Search more.